Bacterial Expression Tech Prompts NorthX and enGenes Collaboration (opens in new tab)
Interest in E.coli-based expression systems is growing as biopharma firms look for faster and cheaper ways of making proteins at commercial scale, prompting the new partnership between NorthX Biologics and enGenes Biotech. The post appeared first on .
Read the original article